Clinical Trial Update: Thrombolysis in Myocardial Infarction (TIMI) [Phase 3]

View source ↗

Summary

The TIMI Phase 3 trial update indicates the study has completed; no results are reported in this document.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease
• Myocardial Infarction
• Myocardial Ischemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED